亏损不断，爱司凯控股股东拟“输血”救急

Core Viewpoint - Aisike announced a plan to issue A-shares to specific investors, raising between 80 million and 120 million yuan, primarily to supplement working capital, while terminating a previous plan for 2024 [1][2]. Group 1: Stock Issuance Details - The stock issuance will involve the controlling shareholder, Aisute, subscribing to the shares in cash [1]. - The total amount to be raised is not less than 80 million yuan and not more than 120 million yuan, with the net proceeds after issuance costs allocated entirely to working capital [1]. - The number of shares to be issued is determined by dividing the total amount raised by the issuance price of 22.83 yuan per share, with a minimum of 3.5042 million shares and a maximum of 5.2562 million shares, not exceeding 30% of the total share capital before the issuance [1]. Group 2: Market Context - The issuance price represents a discount of approximately 25% compared to Aisike's latest closing price of 30.65 yuan per share, with a total market capitalization of 4.589 billion yuan [2]. - Aisike's stock has seen an overall increase of nearly 50% this year [2]. Group 3: Company Performance - Aisike has reported losses for three consecutive years, continuing to incur losses in the first three quarters of this year [5][6]. - For the first three quarters of this year, the company achieved total operating revenue of 120 million yuan, a year-on-year decrease of 2.24%, with a net profit loss attributable to shareholders of 19.8452 million yuan, compared to a loss of 9.6057 million yuan in the same period last year [7]. - The company is in a strategic transition from traditional CTP to high-end CTP and metal additive manufacturing, facing high expenses due to significant prior capital investments [6].